In the face of increasing reports of adverse events and death rates that are 400% higher than other vaccines, Merck continues to maintain that its controversial Gardasil vaccine is safe and continues to push for wider use. One group Merck would especially like to gain approval for is older women (currently, the vaccine is not approved for women over 27 years old). Despite Merck's claims to the contrary, studies have actually shown that Gardasil and its sister vaccine Cervarix (from GlaxoSmithKline) provide no protection for women already exposed to the HPV virus and in fact present highly elevated risks for already exposed women as well as for expectant mothers. Read More.

The Best Colloidal Silver
on the Planet